RNA interference mediated inhibition of NOGO and NOGO receptor gene expression using short interfering RNA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

10206693

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns methods and reagents useful in modulating gene expression in a variety of applications, including use in therapeutic, diagnostic, target validation, and genomic discovery applications associated with Alzheimer's disease. Specifically, the invention relates to small interfering RNA (siRNA) molecules capable of mediating RNA interference (RNAi) against NOGO and NOGO receptor (NOGOr) polypeptide and polynucleotide targets.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIBOZYME PHARMACEUTICALS INC2950 WILDERNESS PLACE BOULDER CO 80301

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
McSwiggen, James A Boulder, CO 30 1909

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation